WallStreetZenWallStreetZen

NYSE: TEVA
Teva Pharmaceutical Industries Ltd Stock

$10.73-0.03 (-0.28%)
Updated Feb 6, 2023
TEVA Price
$10.73
Fair Value Price
N/A
Market Cap
$11.92B
52 Week Low
$6.78
52 Week High
$11.45
P/E
-9.25x
P/B
1.36x
P/S
0.59x
PEG
N/A
Dividend Yield
N/A
Revenue
$15.14B
Earnings
-$1.29B
Gross Margin
47.9%
Operating Margin
-7.47%
Profit Margin
-8.5%
Debt to Equity
3.96
Operating Cash Flow
$1B
Beta
1.08
Next Earnings
Feb 8, 2023
Ex-Dividend
N/A
Next Dividend
N/A

TEVA Overview

Teva Pharmaceutical Industries Limited manufactures,and distributes generic medicines, specialty medicines, and biopharmaceutical products in the U.S. and internationally. Offerings include sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage forms (tablets, capsules, injectables, inhalants, liquids, transdermal patches, ointments, and creams). Teva focuses on the central nervous system, pain, respiratory, and oncology areas. Its product, Copaxone, treats relapsing forms of multiple sclerosis. The company was founded in 1901 and is headquartered in Tel Aviv-Yafo, Israel.

Zen Score

Industry Average (27)
You've viewed Zen Score for 10/10 free stocks. Upgrade to Premium to see how TEVA scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.

Due Diligence Checks

TEVA is unprofitable, so we are unable to calculate its intrinsic value according to an updated version of Benjamin Graham's Formula from "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
TEVA is good value based on its book value relative to its share price (1.36x), compared to the US Drug Manufacturers - Specialty & Generic industry average (1.9x)
P/B vs Industry Valuation
TEVA is unprofitable, so we... subscribe to Premium to read more.
PEG Value Valuation
There are 35 more TEVA due diligence checks available for Premium users.

Be the first to know about important TEVA news, forecast changes, insider trades & much more!

TEVA News

Valuation

TEVA price to earnings (PE)

For valuing profitable companies with steady earnings
Company
-9.25x
Industry
18.21x
Market
14.99x

TEVA price to book (PB)

For valuing companies that are loss-making or have lots of physical asset
Company
1.36x
Industry
1.9x
TEVA is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation

TEVA's financial health

Profit margin

Revenue
$3.6B
Net Income
$56.0M
Profit Margin
1.6%
TEVA's Earnings (EBIT) of -$1.13B... subscribe to Premium to read more.
Interest Coverage Financials
TEVA's profit margin has decreased... subscribe to Premium to read more.
Profit Margin Growth Financials

Assets to liabilities

Assets
$44.3B
Liabilities
$34.7B
Debt to equity
3.96
TEVA's short-term liabilities ($11.53B) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
TEVA's long-term liabilities ($23.20B) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
TEVA's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials

Cash flow

Operating
$543.0M
Investing
$147.0M
Financing
-$440.0M
TEVA's operating cash flow ($1.07B)... subscribe to Premium to read more.
Debt Coverage Financials

TEVA vs Pharmaceutical Stocks

TickerMarket Cap1d %P/EP/B
TEVA$11.92B-0.28%-9.25x1.36x
CTLT$12.06B+19.54%28.51x2.57x
VTRS$14.61B-1.07%18.26x0.76x
RDY$8.81B-0.24%29.23x3.63x
ELAN$6.54B-0.58%-57.46x0.97x

Teva Pharmaceutical Industries Stock FAQ

What is Teva Pharmaceutical Industries's quote symbol?

NYSE: TEVA) Teva Pharmaceutical Industries trades on the NYSE under the ticker symbol TEVA. Teva Pharmaceutical Industries stock quotes can also be displayed as NYSE: TEVA.

If you're new to stock investing, here's how to buy Teva Pharmaceutical Industries stock.

What is the 52 week high and low for Teva Pharmaceutical Industries (NYSE: TEVA)?

(NYSE: TEVA) Teva Pharmaceutical Industries's 52-week high was $11.45, and its 52-week low was $6.78. It is currently -6.25% from its 52-week high and 58.28% from its 52-week low.

How much is Teva Pharmaceutical Industries stock worth today?

(NYSE: TEVA) Teva Pharmaceutical Industries currently has 1,110,644,809 outstanding shares. With Teva Pharmaceutical Industries stock trading at $10.73 per share, the total value of Teva Pharmaceutical Industries stock (market capitalization) is $11.92B.

Teva Pharmaceutical Industries stock was originally listed at a price of $5.91 in Dec 31, 1997. If you had invested in Teva Pharmaceutical Industries stock at $5.91, your return over the last 25 years would have been 81.43%, for an annualized return of 2.41% (not including any dividends or dividend reinvestments).

How much is Teva Pharmaceutical Industries's stock price per share?

(NYSE: TEVA) Teva Pharmaceutical Industries stock price per share is $10.73 today (as of Feb 6, 2023).

What is Teva Pharmaceutical Industries's Market Cap?

(NYSE: TEVA) Teva Pharmaceutical Industries's market cap is $11.92B, as of Feb 7, 2023.

Market cap (market capitalization) is the total market value of a publicly traded company's outstanding shares.

Teva Pharmaceutical Industries's market cap is calculated by multiplying TEVA's current stock price of $10.73 by TEVA's total outstanding shares of 1,110,644,809.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.